来那度胺对复发或难治性多发性骨髓瘤的髓外病变有效。 - Suppr

Suppr

超能文献

Lenalidomide is effective for extramedullary disease in relapsed or refractory multiple myeloma.

作者信息

Calvo-Villas José M, Alegre Adrián, Calle Carmen, Hernández Miguel T, García-Sánchez Ricarda, Ramírez Gema

出版信息

Eur J Haematol. 2011 Sep;87(3):281-4. doi: 10.1111/j.1600-0609.2011.01644.x. Epub 2011 Jul 26.

DOI:10.1111/j.1600-0609.2011.01644.x

PMID:21557775

Abstract

摘要

相似文献

Lenalidomide is effective for extramedullary disease in relapsed or refractory multiple myeloma.来那度胺对复发或难治性多发性骨髓瘤的髓外病变有效。

Eur J Haematol. 2011 Sep;87(3):281-4. doi: 10.1111/j.1600-0609.2011.01644.x. Epub 2011 Jul 26.

Management of the relapsed/refractory myeloma patient: strategies incorporating lenalidomide.复发/难治性骨髓瘤患者的管理：包含来那度胺的策略

Semin Hematol. 2005 Oct;42(4 Suppl 4):S9-15. doi: 10.1053/j.seminhematol.2005.10.004.

Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma.来那度胺联合地塞米松治疗复发或难治性多发性骨髓瘤。

N Engl J Med. 2007 Nov 22;357(21):2123-32. doi: 10.1056/NEJMoa070594.

Previous thalidomide therapy may not affect lenalidomide response and outcome in relapse or refractory multiple myeloma patients.先前的沙利度胺治疗可能不会影响复发或难治性多发性骨髓瘤患者对来那度胺的反应和结果。

Eur J Cancer. 2011 Apr;47(6):814-8. doi: 10.1016/j.ejca.2010.12.026. Epub 2011 Feb 18.

Lenalidomide: new drug. Myeloma: many questions remain unanswered.来那度胺：新药。骨髓瘤：诸多问题仍未得到解答。

Prescrire Int. 2008 Dec;17(98):230-2.

Thalidomide and lenalidomide in multiple myeloma.沙利度胺和来那度胺在多发性骨髓瘤中的应用

Best Pract Res Clin Haematol. 2006;19(4):769-80. doi: 10.1016/j.beha.2006.06.006.

Lenalidomide in combination with dexamethasone: effective regimen in patients with relapsed or refractory multiple myeloma complicated by renal impairment.来那度胺联合地塞米松：治疗伴有肾功能损害的复发或难治性多发性骨髓瘤患者的有效方案。

Ann Hematol. 2011 Apr;90(4):429-39. doi: 10.1007/s00277-010-1080-4. Epub 2010 Sep 21.

Thalidomide, lenalidomide and bortezomib in the management of newly diagnosed multiple myeloma.沙利度胺、来那度胺和硼替佐米在新诊断多发性骨髓瘤中的治疗作用。

Expert Rev Hematol. 2011 Feb;4(1):51-60. doi: 10.1586/ehm.10.83.

Thalidomide and lenalidomide in the treatment of multiple myeloma.沙利度胺和来那度胺治疗多发性骨髓瘤

Eur J Cancer. 2006 Jul;42(11):1612-22. doi: 10.1016/j.ejca.2006.04.004. Epub 2006 Jun 5.

Lenalidomide in the treatment of multiple myeloma: a review.来那度胺治疗多发性骨髓瘤的综述

J Clin Pharm Ther. 2008 Jun;33(3):219-26. doi: 10.1111/j.1365-2710.2008.00920.x.

引用本文的文献

Therapeutic options for extramedullary involvement in multiple myeloma.多发性骨髓瘤髓外浸润的治疗选择。

Clin Exp Med. 2025 Aug 23;25(1):301. doi: 10.1007/s10238-025-01821-w.

Challenges in the treatment of soft-tissue plasmacytoma: a retrospective analysis of 120 patients with extramedullary multiple myeloma.软组织浆细胞瘤治疗的挑战：120 例髓外多发性骨髓瘤患者的回顾性分析。

J Cancer Res Clin Oncol. 2024 Oct 29;150(10):482. doi: 10.1007/s00432-024-05993-y.

Multiple Myeloma in 2023 Ways: From Trials to Real Life.2023 年多发性骨髓瘤的多种治疗方法：从临床试验到现实生活。

Curr Oncol. 2023 Nov 3;30(11):9710-9733. doi: 10.3390/curroncol30110705.

A Case of Recurrent Multiple Myeloma as Testicular Plasmacytoma Without Systemic Disease.一例复发性多发性骨髓瘤表现为睾丸浆细胞瘤且无系统性疾病

Cureus. 2023 Jun 22;15(6):e40785. doi: 10.7759/cureus.40785. eCollection 2023 Jun.

Advances in the treatment of extramedullary disease in multiple myeloma.多发性骨髓瘤髓外疾病的治疗进展

Transl Oncol. 2022 Aug;22:101465. doi: 10.1016/j.tranon.2022.101465. Epub 2022 Jun 6.

Anti-BCMA CAR-T Cell Therapy in Relapsed/Refractory Multiple Myeloma Patients With Extramedullary Disease: A Single Center Analysis of Two Clinical Trials.抗 BCMA CAR-T 细胞疗法在伴有髓外疾病的复发/难治性多发性骨髓瘤患者中的应用：两项临床试验的单中心分析。

Front Immunol. 2021 Oct 29;12:755866. doi: 10.3389/fimmu.2021.755866. eCollection 2021.

Autologous stem cell transplantation in EBV-positive post-renal transplant refractory multiple myeloma: A case report and literature review.EBV 阳性肾移植后难治性多发性骨髓瘤的自体干细胞移植：一例报告及文献综述

Oncol Lett. 2018 May;15(5):7207-7214. doi: 10.3892/ol.2018.8237. Epub 2018 Mar 12.

Impact of extramedullary disease in patients with newly diagnosed multiple myeloma undergoing autologous stem cell transplantation: a study from the Chronic Malignancies Working Party of the EBMT.新诊断多发性骨髓瘤患者自体干细胞移植后髓外疾病的影响：来自 EBMT 慢性恶性肿瘤工作组的研究。

Haematologica. 2018 May;103(5):890-897. doi: 10.3324/haematol.2017.178434. Epub 2018 Feb 1.

Clinical features of multiple myeloma patients with isolated extramedullary relapse.孤立性髓外复发的多发性骨髓瘤患者的临床特征

J Biomed Res. 2018 Jul 23;32(4):264-269. doi: 10.7555/JBR.31.20140090.

Successful treatment with lenalidomide of secondary multiple myeloma with extramedullary liver plasmacytoma in a renal transplant recipient: A case report and review of the literature.来那度胺成功治疗肾移植受者合并肝髓外浆细胞瘤的继发性多发性骨髓瘤：一例报告并文献复习

Oncol Lett. 2015 Nov;10(5):2931-2936. doi: 10.3892/ol.2015.3729. Epub 2015 Sep 18.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验